ArticlePloS one2026
Hemodynamic effects of prophylactic amiodarone assessed by pressure-volume analysis in anesthetized female pigs in sinus rhythm-An exploratory study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntravenous amiodarone is used for acute management of severe arrhythmias and can cause hypotension. However, amiodarone's direct hemodynamic and myocardial effects during sinus rhythm are not well characterized.
methodsTwenty-five anesthetized female pigs (75-80 kg) received a 300 mg intravenous bolus amiodarone over 30 minutes. To assess hemodynamic effects, animals were instrumented with a left ventricular conductance catheter, a pulmonary artery catheter, a carotid artery Doppler flow probe, and a renal vein catheter. Data were recorded at baseline, after 15 and 30 minutes and presented as median with interquartile ranges.
resultsAmiodarone reduced systolic and mean arterial blood pressure by 12% (p < 0.001) after 30 minutes infusion, primarily driven by 24% reduction in cardiac output due to combined deceased heart rate (87 (79; 99) beats per minute (bpm) to 72 (62; 81) bpm, p < 0.001) and stroke volume (69 (64; 79) mL to 64 (48; 73) mL, p = 0.004). End-systolic elastance (EES) decreased (0.54 (0.33; 0.63) mmHg/mL to 0.43 (0.29; 0.51) mmHg/mL, p < 0.001), while systemic vascular resistance and arterial elastance (EA) remained unchanged, resulting in an increased EA/EES ratio from 2.45 (2.01;3.53) to 3.26 (2.55; 4.30) (p < 0.001). This impaired cardiac function led to reduced carotid artery blood flow and renal perfusion pressure.
conclusionInfusion of 300 mg amiodarone intravenously in anesthetized pigs in sinus rhythm impaired left ventricular contractility and caused ventriculo-arterial decoupling with increased EA/EES ratio. This led to reduced cardiac output, blood pressure, and reduced carotid- and renal blood flow.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.